| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |